The Unloved Child Podcast

JCR Pharma

The Unloved Child is a podcast exploring the overlooked side of pharmaceutical and life science development. Hosted by James Carpenter of JCR Pharma Ltd, each episode features honest conversations with experts across biometrics, biostatistics, statistical programming, data science, bioinformatics, and clinical data management. Together, we uncover the vital work happening behind the scenes, the challenges faced, and the innovations shaping the future of healthcare.

Episodes

  1. Jul 21

    Daniel Sakya| Director of Statistical Programming| Neumora

    The Unloved Child Podcast | Daniel Sakya | Director of Statistical Programming at Neumora What does a Director of Statistical Programming actually do, and how does statistical programming help bring new medicines to patients? In this episode of The Unloved Child Podcast, we sit down with Daniel Sakya, Director of Statistical Programming at Neumora, to explore the world of statistical programming in drug development. Daniel shares the personal experiences that inspired him to pursue a career in the pharmaceutical industry, discusses how the profession has evolved over the years, and explains the vital role statistical programmers play in delivering high-quality clinical trial data to regulatory authorities. Whether you're considering a career in biometrics, already work in clinical development, or simply want to understand how medicines make it from clinical trials to patients, this episode provides an insightful look behind the scenes of modern drug development. Daniel's career journey and what led him into statistical programming.How family experiences with illness inspired him to work in drug development.What statistical programmers do throughout the lifecycle of a clinical trial.The importance of CDISC standards and why data standardisation has transformed the industry.What goes into preparing regulatory submissions for the FDA, EMA, and other global health authorities.The programming languages used in clinical research, including SAS and R, and how they're applied.How the role of statistical programming has changed over the years.The future of statistical programming and emerging trends within the pharmaceutical industry.

    Daniel Sakya| Director of Statistical Programming| Neumora
  2. Jun 1

    Doug Leonard| Senior Director, Statistical Programming| Beacon Therapeutics

    🎙️ In this episode, we sit down with Doug Leonard, Senior Director of Statistical Programming at Beacon Therapeutics, for an insightful conversation about his 20+ year career in clinical data analytics, statistical programming, and leadership across the biotech and pharmaceutical industries. Doug shares his experiences building programming organisations from the ground up, leading global teams, supporting major FDA submissions, and adapting to the rapidly evolving world of clinical research and statistical computing. We discuss Doug’s career journey in statistical programming and biotech, how the landscape of programming and clinical data science is changing, leadership lessons from managing high-performing global teams, and the impact of AI, automation, and emerging technologies on the industry. Doug also offers valuable advice for the next generation of statistical programmers and clinical research professionals, highlighting the importance of mentorship, adaptability, and continuous learning. The conversation also explores Doug’s proudest career moments and his contributions to groundbreaking therapies and important regulatory milestones. He reflects on the future of statistical programming, the growing importance of innovation in biotech, and what professionals can do to build long-term success in a fast-moving industry. Whether you work in SAS programming, biostatistics, clinical data management, biotech, or pharmaceutical research, this episode offers valuable career insights and leadership perspectives from one of the industry’s experienced professionals. Follow for more conversations with leaders in biotech, clinical research, healthcare innovation, and statistical programming. #StatisticalProgramming #ClinicalResearch #SASProgramming #Biotech #FDA #DataAnalytics #PharmaceuticalIndustry #Biostatistics #Leadership #CareerAdvice #BeaconTherapeutics #ClinicalData #HealthcareInnovation

    Doug Leonard| Senior Director, Statistical Programming| Beacon Therapeutics
  3. Mar 2

    Srinivasa Mukkala| Unloved Child| VP of Operations, Biostatistics and Programming| Epis Data

    Leadership in Biostatistics: Driving FDA Approvals in Gene Therapy and Clinical Research In this episode, we speak with Srinivasa Reddy Mukkala, Vice President of Operations – Biostatistics and Statistical Programming at EPIS DATA, about the critical role of statistical leadership in regulatory success. Srinivasa has contributed to multiple FDA approvals, including breakthrough gene therapies such as ZYNTEGLO for Beta-Thalassemia and LYFGENIA for Sickle Cell Disease. He also served as statistical programming lead for NUZYRA, an FDA-approved tetracycline-class antibiotic. We explore: The role of biostatistics and statistical programming in FDA submissions Delivering regulatory-ready clinical trial data The complexity of gene therapy trials Leadership in biometrics and global operations Career progression from pharmacist to data science executive The future of clinical research, regulatory science, and data integrity This conversation is essential listening for professionals in biostatistics, statistical programming, clinical data management, regulatory affairs, pharmaceutical development, and life sciences leadership. If you are involved in clinical trials, gene therapy, FDA submissions, or biometrics strategy, this episode offers practical insights from someone who has helped bring transformative therapies to patients worldwide. Subscribe for more conversations with leaders shaping the future of biostatistics, clinical research, and pharmaceutical innovation.

    Srinivasa Mukkala| Unloved Child| VP of Operations, Biostatistics and Programming| Epis Data

About

The Unloved Child is a podcast exploring the overlooked side of pharmaceutical and life science development. Hosted by James Carpenter of JCR Pharma Ltd, each episode features honest conversations with experts across biometrics, biostatistics, statistical programming, data science, bioinformatics, and clinical data management. Together, we uncover the vital work happening behind the scenes, the challenges faced, and the innovations shaping the future of healthcare.